Cell Signaling Technology Logo
1% for the planet logo
Trial Size Available Flag
Recombinant Flag
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

FHL2 (E5E3D) Rabbit mAb #35602

Filter:
  • WB

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 28
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    FHL2 (E5E3D) Rabbit mAb recognizes endogenous levels of total FHL2 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu14 of human FHL2 protein.

    Background

    Four and a half LIM-only protein 2 (FHL2) is a member of the LIM domain protein family that interacts with a large number of proteins, including receptors, signal transducers, and transcription factors (1). LIM proteins have one or more LIM domains composed of a conserved cysteine-rich module that mediates protein interactions (2). FHL2 is involved in regulating various cellular processes, such as survival, proliferation, migration, and signal transduction in muscle and cardiac tissue (1-3). In immune cells, FHL2 has been shown to play a role in B cell differentiation and maturation in secondary lymphoid organs, and its deletion alters cytokine release and migration of dendritic cells and macrophages (4,5). FHL2 binds FOXO1, resulting in decreased expression of genes targeted by FOXO (6). FHL2 suppresses tumor growth by interacting directly with HIF-1α and repressing its transcriptional activity (7). When upregulated in tumors, FHL2 can also act as an oncoprotein interacting with multiple transcription factors to suppress apoptosis and promote tumor progression (8). For these reasons, FHL2 is being investigated as a tumor therapeutic target.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.